StonvexLoading…
StonvexStonvexStonvexCore line items from ACGL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.93B | $17.44B | $13.63B | $9.61B |
Operating Income | $5.16B | $4.67B | $3.57B | $1.56B |
Net Income | $4.40B | $4.31B | $4.44B | $1.48B |
EPS (Diluted) | $11.60 | $11.19 | $11.62 | $3.80 |
Total Assets | $79.24B | $70.91B | $58.91B | $47.99B |
Total Liabilities | $55.03B | $50.09B | $40.55B | $35.07B |
Cash & Equivalents | $993.00M | $979.00M | $917.00M | $855.00M |
Free Cash Flow OCF − CapEx | $6.13B | $6.62B | $5.70B | $3.77B |
Shares Outstanding | 359.00M | 376.40M | 373.40M | 370.40M |